(E)-3-(benzo[d][1,3]dioxol-5-yl)-N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)acrylamide
(E)-3-(苯并[d][1,3]二氧杂环戊烯-5-基)-N-(3,3,5-三甲基-4-氧代-2,3,4,5-四氢苯并[b][1,4]氧氮杂䓬-8-基)丙烯酰胺
(E)-3-(benzo[d][1,3]dioxol-5-yl)-N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)acrylamide (CAS 1207062-09-6) is a compound in the Organic Bases category listed in the Jingsj chemical database. It has the molecular formula C22H22N2O5 and a molecular weight of 394.4 g/mol. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 1207062-09-6
- Jingsj CID
- J-522788-2
- Molecular Formula
- C22H22N2O5
- Chinese Name
- (E)-3-(苯并[d][1,3]二氧杂环戊烯-5-基)-N-(3,3,5-三甲基-4-氧代-2,3,4,5-四氢苯并[b][1,4]氧氮杂䓬-8-基)丙烯酰胺
- Molecular Weight
- 394.4 g/mol
- Category
- Organic Bases
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quoteFrequently Asked Questions
What is the CAS number of (E)-3-(benzo[d][1,3]dioxol-5-yl)-N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)acrylamide?
The CAS number of (E)-3-(benzo[d][1,3]dioxol-5-yl)-N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)acrylamide is 1207062-09-6.
What are the molecular formula and molecular weight of (E)-3-(benzo[d][1,3]dioxol-5-yl)-N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)acrylamide?
(E)-3-(benzo[d][1,3]dioxol-5-yl)-N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)acrylamide has molecular formula C22H22N2O5 and molecular weight 394.4 g/mol.
Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "(E)-3-(benzo[d][1,3]dioxol-5-yl)-N-(3,3,5-trimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-8-yl)acrylamide (CAS 1207062-09-6)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-522788-2 (accessed 2026-10-24).
Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.